References
- The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global initiative for chronic obstructive lung disease (GOLD) 2018. Available from: http://goldcopd.org. Accessed 1220, 2018.
- World Health Organization. Chronic obstructive pulmonary disease (COPD). Available from: http://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed 1220, 2018.
- Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–1757. doi:10.1016/S0140-6736(06)68770-916731270
- Calverley PM. Cough in chronic obstructive pulmonary disease: is it important and what are the effects of treatment? Cough. 2013;9:17. doi:10.1186/1745-9974-9-1723799979
- Muñoz A, Small M, Wood R, Ribera A, Nuevo J. The impacts of morning, daytime, and nighttime symptoms on disease burden in real-world patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:1557–1568. doi:10.2147/COPD.S15787429805254
- Gutzwiller FS, Gruenberger JB, Kaur VP, et al. Generating patient insights in chronic obstructive pulmonary disease (COPD) with social media listening study. Eur Respir J. 2018;52:PA2005. doi:10.1183/13993003.01675-2018
- Smith J, Woodcock A. Cough and its importance in COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(3):305–314.18046867
- Patient-focused drug development public workshop on guidance 1: collecting comprehensive and representative input discussion document. Available from: https://www.fda.gov/drugs/newsevents/ucm574725.htm. Accessed 1225, 2018.
- Todres L. The humanization of healthcare: a value framework for qualitative research. Int J Qual Stud Health Well-Being. 2009;4:68–77. doi:10.1080/17482620802646204
- Anderson C. Presenting and evaluating qualitative research. Am J Pharm Educ. 2010;74(8):141. doi:10.5688/aj740814121179252
- Fan VS, Meek PM. Anxiety, depression, and cognitive impairment in patients with chronic respiratory disease. Clin Chest Med. 2014;35(2):399–409. doi:10.1016/j.ccm.2014.02.01224874134
- von Leupoldt A, Kenn K. The psychology of chronic obstructive pulmonary disease. Curr Opin Psychiatry. 2013;26(5):458–463. doi:10.1097/YCO.0b013e328363c1fc23867658
- Douglas A Make the most of online ‘Bulletin board’ groups for qualitative research. Available from: http://www.bain.com/publications/articles/make-the-most-of-online-bulletin-board-groups-for-qualitative-research.aspx. Accessed 1220, 2018
- The Association of Qualitative Research. Online bulletin board. Available from: https://www.aqr.org.uk/glossary/online-bulletin-board. Accessed 1220, 2018.
- Green Book Directory. Online bulletin board. Available from: https://www.greenbook.org/market-research-firms/online-bulletin-boards. Accessed 1220, 2018.
- ICC/ESOMAR International Code on Market, Opinion and social research and data analytics. Available from: https://www.esomar.org/uploads/public/knowledge-and-standards/codes-and-guidelines/ICCESOMAR_Code_English_.pdf. Accessed 1220, 2018.
- EphMRA code of conduct. Available from: https://www.ephmra.org/media/1044/ephmra-2017-code-of-conduct-october-2017.pdf. Accessed 1220, 2018.
- Intellus code of conduct. Available from: https://www.intellus.org/Standards-Guidelines/Code-of-Conduct. Accessed 1220, 2018.
- The Association of British Pharmaceutical Industry (ABPI) code of conduct. Available from: https://www.abpi.org.uk/ethics/ethical-responsibility/disclosure-uk/resources/. Accessed 1220, 2018.
- Market Research Society code of conduct. Available from: https://www.mrs.org.uk/standards/code_of_conduct. Accessed 1220, 2018.
- BHBIA Legal and Ethical Guidelines for Healthcare Market Research. Available from: https://www.bhbia.org.uk/guidelines/legalandethicalguidelines.aspx. Accessed 1220, 2018.
- Baiardini I, Rogliani P, Santus P, et al. Disease awareness in patients with COPD: measurement and extent. Int J Chron Obstruct Pulmon Dis. 2018;14:1–11. doi:10.2147/COPD.S17978430587957
- Chen S, Small M, Lindner L, Xu X. Symptomatic burden of COPD for patients receiving dual or triple therapy. Int J Chron Obstruct Pulmon Dis. 2018;13:1365–1376. doi:10.2147/COPD.S16371729731624
- Price D, Small M, Milligan G, Higgins V, Garcia Gil E, Estruch J. Impact of night-time symptoms in COPD: a real-world study in five European countries. Int J Chron Obstruct Pulmon Dis. 2013;8:595–603. doi:10.2147/COPD.S4857024348032
- Stephenson JS, Cai Q, Mocarski M, Tan H, Doshi JA, Sullivan SD. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:577–586. doi:10.2147/COPD.S7615725844033
- Miravitlles M, Anzueto A, Legnani D, Forstmeier L, Fargel M. Patient’s perception of exacerbations of COPD–the PERCEIVE study. Respir Med. 2007;101:453–460. doi:10.1016/j.rmed.2006.07.01016938447
- Monteagudo M, Rodríguez-Blanco T, Llagostera M, et al. Factors associated with changes in quality of life of COPD patients: a prospective study in primary care. Respir Med. 2013;107:1589–1597. doi:10.1016/j.rmed.2013.05.00923786889
- Kessler R, Partridge MR, Miravitlles M, et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J. 2011;37:264–272. doi:10.1183/09031936.0005111021115606
- Hirayama F, Binns CW, Lee AH, Senjyu H. Urinary incontinence in Japanese women with chronic obstructive pulmonary disease: review. J Phys Ther Sci. 2005;17:119–124. doi:10.1589/jpts.17.119
- Jarad NA, Patel P, Buswell G. Epidemiology and risk factors of urinary incontinence in patients with chronic obstructive pulmonary disease (COPD). West Engl Med J. 2015;114(3):1–3.
- Maggi S, Minicuci N, Langlois J, Pavan M, Enzi G, Crepaldi G. Prevalence rate of urinary incontinence in community-dwelling elderly individuals: the Veneto study. J Gerontol A Biol Sci Med Sci. 2001;56(1):M14–18. doi:10.1093/gerona/56.1.M1411193226
- Hrisanfow E, Hägglund D. Impact of cough and urinary incontinence on quality of life in women and men with chronic obstructive pulmonary disease. J Clin Nurs. 2013;22(1–2):97–105. doi:10.1111/jocn.2012.22.issue-1pt222805299
- Dury R. COPD and emotional distress: not always noticed and therefore untreated. Br J Community Nurs. 2016;21:138–141. doi:10.12968/bjcn.2016.21.3.13826940616
- Deslee G, Burgel PR, Escamilla R, et al. Impact of current cough on health-related quality of life in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2091–2097. doi:10.2147/COPD.S10688327695305
- Wacker ME, Kitzing K, Jörres RA, et al. The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort. Int J COPD. 2017;12:3437–3448. doi:10.2147/COPD.S141852
- Miravitlles M, Ferrer J, Baro E, Lleonart M, Galera J. Differences between physician and patient in the perception of symptoms and their severity in COPD. Respir Med. 2013;107:1977–1985. doi:10.1016/j.rmed.2013.06.01923890959
- Anderson C. Presenting and evaluating qualitative research. Am J Pharm Ed. 2010;74:141. doi:10.5688/aj7408141